Skip to main content
    T

    Tiziana Life Sciences Ltd (TLSA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.58
    +0.01 (+1.11%)

    Market Cap: $72.53M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    11%(1/9)
    Avg Surprise
    -80.66%
    Last 12 of 29 reported quarters
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Jun 26
    Reported Aug 7
    N/AN/AN/A-----
    Sep 25
    Reported Oct 13
    -$0.05N/AN/A----+72.3%
    Jun 25
    Reported Jul 8
    -$0.10-$0.07N/A-35.38%Miss--+55.5%
    Mar 25
    Reported May 20
    -$0.07N/AN/A-----16.7%
    Sep 24
    Reported Oct 18
    -$0.05N/AN/A----+16.7%
    Jun 24
    Reported Jun 30
    -$0.18N/AN/A-----
    Dec 22
    Reported Apr 26
    -$0.22N/AN/A-----170.5%
    Sep 22
    Reported Dec 27
    -$0.06N/AN/A-----6.2%
    Mar 22
    Reported May 22
    -$0.06-$0.06N/A0.00%In line---3.8%
    Sep 21
    Reported Dec 1
    Not reportedN/AN/A-----
    Jun 21
    Reported Sep 24
    -$0.08N/AN/A-----102.0%
    Mar 21
    Reported May 17
    -$0.06-$0.04N/A-42.68%Miss---42.7%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-781.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio0.69xQuick Ratio0.69x
    Trading Statistics
    Beta0.46Avg Volume533.34K
    52-Week High$1.9052-Week Low$0.57

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 37.0% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 29.1, below 30, the oversold line.

    Moving Averages

    SMA 10$0.63
    SMA 20$0.77
    SMA 50$0.92
    SMA 200$1.16
    EMA 10$0.65
    EMA 20$0.74
    EMA 50$0.88
    EMA 200$1.14

    MACD

    Line: -0.11Signal: -0.10Hist: -0.01

    ADX

    ADX: 37.6+DI: 8.7-DI: 33.3

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$0.68

    Bollinger Bands

    Upper Band$1.09
    Lower Band$0.44
    %B Position8446%(Upper)
    Band Width0.21

    RSI (14-Day)

    Oversold
    29.1

    Momentum Oscillators

    Stoch %K6.2
    Stoch %D8.6
    Williams %R-93.7
    ROC (10d)-14.0%
    Momentum-0.09
    CCI (20d)-90.1
    MFI (14d)10.7

    Volatility Measures

    ATR (14d)$0.08(13.5%)
    StdDev (20d)0.16
    Hist Vol101.7%(High)

    Volume Flow

    VWAP$0.58
    OBV-10.3M
    AD Line-7.4M
    CMF (20d)-0.346

    Volume Metrics

    Avg Vol (20d)543.4K
    Vol Ratio1.2x
    VWMA (20d)$0.73

    Pivot Points

    R3$0.67
    R2$0.65
    R1$0.61
    Pivot Point$0.59
    S1$0.55
    S2$0.52
    S3$0.48

    Advanced Oscillators

    TSI-37.54
    Ultimate Osc31.4
    KST-339.74

    Financial Data

    QuarterSep 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total RevenueN/AN/A$0N/AN/AN/A$0N/AN/AN/AN/AN/A
    Cost of Revenue$158.00K$11.95M$146.00K$88.00K$88.00K$9.29M$61.00K$126.00K$126.00K$9.29M$41.00K-$51.92K
    Gross Profit-$158.00K-$11.95M-$146.00K-$88.00K-$88.00K-$9.29M-$61.00K-$126.00K-$126.00K-$9.29M-$41.00K-$55.00K
    Operating Expenses$11.37M$12.18M$12.18M$9.19M$8.87M$9.13M$9.13M$6.51M$12.76M$6.19M$6.19M$8.69M
    R&D$6.43M$7.04M$7.04M$3.24M$3.24M$2.65M$2.65M$2.58M$5.15M$4.83M$4.83M$3.29M
    SG&A$0$0$5.15M$0$0$0$6.48M$0$0$0$0$5.41M
    Operating Income-$11.37M-$11.95M-$12.33M-$9.19M-$8.96M-$9.29M-$9.19M-$6.51M-$12.89M-$9.29M-$6.23M-$8.69M
    Interest Income$0$0$14.00K$0$0$0$702.00K$0$0$0$0$0
    Interest Expense$1.01M$18.00K$18.00K$0$0$6.00K$6.00K$1.47M$3.07M$5.00K$5.00K$5.00K
    Income Before Tax-$12.39M-$12.80M-$12.80M-$5.63M-$5.63M-$8.77M-$8.77M-$7.98M-$15.96M-$8.63M-$8.63M-$8.62M
    Income Tax Expense$0$0$0$0$0-$1.56M-$1.56M-$3.33M-$6.65M$449.00K$449.00K$0
    Net Income-$12.39M-$12.80M-$12.80M-$5.63M-$5.63M-$7.21M-$7.21M-$4.65M-$9.31M-$9.07M-$9.07M-$8.62M
    EBITDA-$12.23M-$12.65M-$12.18M-$5.54M-$5.54M-$8.70M-$8.70M-$7.92M-$15.83M-$8.58M-$8.58M-$8.56M
    EBIT-$12.39M-$12.80M-$12.33M-$5.63M-$5.63M-$8.76M-$8.76M-$7.98M-$15.96M-$8.62M-$8.62M-$8.61M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TLSA

    News

    TLSA Valuation

    TLSA Profitability: Margins, ROIC and FCF

    Tiziana Life Sciences (TLSA) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -781.0%

    Tiziana Life Sciences Competitors

    The companies most similar to Tiziana Life Sciences (TLSA) include vTv Therapeutics, Kazia Therapeutics Ltd ADR and Oncolytics Biotech.

    Sector: Healthcare

    TLSA Bull Case vs Bear Case

    Bear case

    • TLSA beat EPS estimates in 12.5% of its last 8 reported quarters.

    TLSA Earnings: Beat Rate

    Beat rate
    1 of 8 quarters (12.5%)
    Average surprise
    -61.2%

    Updated Nov 4, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About TLSA

    Does TLSA pay dividends?

    Tiziana Life Sciences Ltd (TLSA) does not currently pay a regular dividend.

    What is TLSA's market cap?

    Tiziana Life Sciences Ltd (TLSA) has a market capitalization of $72.53M with a current stock price of $0.58.

    TLSA pages: Overview

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.